Klingenstein Fields & Co’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$243K Sell
3,380
-375
-10% -$28.9K 0.01% 165
2025
Q4
$298K Hold
3,755
0.01% 152
2025
Q3
$283K Hold
3,755
0.01% 163
2025
Q2
$259K Sell
3,755
-1,173
-24% -$76.9K 0.01% 165
2025
Q1
$334K Buy
4,928
+10
+0.2% +$598 0.01% 142
2024
Q4
$221K Sell
4,918
-223
-4% -$12.5K 0.01% 173
2024
Q3
$323K Sell
5,141
-267,555
-98% -$15.6M 0.01% 145
2024
Q2
$16.1M Sell
272,696
-20,258
-7% -$1.27M 0.67% 52
2024
Q1
$23.4M Sell
292,954
-3,213
-1% -$245K 0.97% 40
2023
Q4
$23.4M Sell
296,167
-707
-0.2% -$50.3K 1.04% 38
2023
Q3
$20.7M Buy
296,874
+8,988
+3% +$637K 1.01% 41
2023
Q2
$19.9M Buy
287,886
+1,270
+0.4% +$90.4K 0.92% 44
2023
Q1
$21.3M Sell
286,616
-1,384
-0.5% -$116K 1.07% 40
2022
Q4
$26.8M Sell
288,000
-4,373
-1% -$422K 1.39% 30
2022
Q3
$27.9M Sell
292,373
-2,805
-1% -$278K 1.53% 20
2022
Q2
$27.4M Sell
295,178
-1,114
-0.4% -$109K 1.42% 26
2022
Q1
$30M Sell
296,292
-2,435
-0.8% -$256K 1.28% 28
2021
Q4
$30.8M Sell
298,727
-16,268
-5% -$1.5M 1.24% 31
2021
Q3
$26.7M Sell
314,995
-6,729
-2% -$564K 1.14% 31
2021
Q2
$26.8M Buy
321,724
+2,896
+0.9% +$237K 1.11% 32
2021
Q1
$24M Buy
318,828
+3,349
+1% +$244K 1.08% 34
2020
Q4
$21.5M Buy
315,479
+3,770
+1% +$245K 0.98% 41
2020
Q3
$18.2M Buy
311,709
+14,706
+5% +$915K 0.91% 47
2020
Q2
$19.3M Buy
297,003
+879
+0.3% +$55.4K 1.05% 36
2020
Q1
$17.6M Sell
296,124
-12,086
-4% -$807K 1.14% 30
2019
Q4
$22.9M Sell
308,210
-10,745
-3% -$754K 1.15% 33
2019
Q3
$20.1M Buy
318,955
+6,361
+2% +$377K 1.06% 39
2019
Q2
$17M Buy
312,594
+7,007
+2% +$377K 0.88% 42
2019
Q1
$16.5M Sell
305,587
-47,298
-13% -$2.92M 0.89% 42
2018
Q4
$23.1M Sell
352,885
-7,976
-2% -$595K 0.98% 37
2018
Q3
$28.4M Buy
360,861
+16,547
+5% +$1.18M 1.02% 35
2018
Q2
$22.2M Buy
344,314
+211,509
+159% +$13.9M 0.84% 43
2018
Q1
$8.26M Buy
132,805
+342
+0.3% +$24.5K 0.32% 70
2017
Q4
$9.6M Sell
132,463
-121,441
-48% -$8.83M 0.35% 69
2017
Q3
$20.6M Buy
253,904
+1,861
+0.7% +$147K 0.79% 49
2017
Q2
$20.3M Buy
252,043
+7,953
+3% +$628K 0.8% 48
2017
Q1
$19.2M Buy
244,090
+126,864
+108% +$10.1M 0.78% 47
2016
Q4
$9.25M Sell
117,226
-159,618
-58% -$12.9M 0.4% 58
2016
Q3
$24.6M Buy
276,844
+4,934
+2% +$466K 1.13% 32
2016
Q2
$26M Buy
271,910
+215,661
+383% +$21.5M 1.22% 22
2016
Q1
$5.83M Buy
56,249
+3,020
+6% +$294K 0.29% 69
2015
Q4
$5.2M Sell
53,229
-1,130
-2% -$111K 0.26% 70
2015
Q3
$5.25M Buy
54,359
+555
+1% +$58.3K 0.26% 68
2015
Q2
$5.64M Sell
53,804
-2,322
-4% -$237K 0.25% 65
2015
Q1
$5.79M Sell
56,126
-699
-1% -$70.7K 0.26% 64
2014
Q4
$5.47M Sell
56,825
-1,925
-3% -$170K 0.24% 67
2014
Q3
$4.68M Sell
58,750
-100
-0.2% -$7.88K 0.2% 71
2014
Q2
$4.43M Sell
58,850
-150
-0.3% -$11.3K 0.19% 72
2014
Q1
$4.42M Sell
59,000
-610
-1% -$43.1K 0.2% 71
2013
Q4
$4.27M Sell
59,610
-5,450
-8% -$350K 0.15% 99
2013
Q3
$3.69M Sell
65,060
-3,890
-6% -$232K 0.14% 103
2013
Q2
$3.94M Buy
+68,950
New +$3.99M 0.14% 109

Other funds holding CVS

Klingenstein Fields & Co's CVS Position: Q1 2026 in Review

Klingenstein Fields & Co reduced its CVS Health (CVS) stake by 10% in Q1 2026, selling an estimated $28.9K and leaving 3,380 shares worth $243K. The position accounts for 0.01% of the portfolio, ranked #165.

Klingenstein Fields & Co first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $30.8M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Klingenstein Fields & Co held 3,380 shares of CVS Health worth $243K as of Q1 2026.
  • Klingenstein Fields & Co sold 375 CVS Health shares in Q1 2026, an estimated $28.9K.
  • CVS Health made up 0.01% of Klingenstein Fields & Co's portfolio in Q1 2026, its #165 holding.
  • Klingenstein Fields & Co first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Klingenstein Fields & Co's CVS Health position peaked at $30.8M in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Klingenstein Fields & Co's 13F filing for Q1 2026, filed 13 May 2026.